Congenital third nerve palsy associated with mid-trimester amniocentesis.

Congenital third nerve palsy associated with mid-trimester amniocentesis.

unilateral congenital third nerve palsy associated with osteogenesis imperfecta

purpose: congenital third nerve palsy was generally thought to exist in isolation without associated abnormalities. in this report, we present a case of congenital third nerve palsy in osteogenesis imperfecta. methods: a 6-month-old girl with osteogenesis imperfceta presented with ptosis and large incomitant exotropia in left eye (le) at birth. ocular examination revealed total third nerve pals...

Fetal loss rates after mid-trimester amniocentesis

Objective: Amniocentesis is an invasive cytogenic test traditionally associated with a 1/200 procedure–related pregnancy loss rate. Recent studies have questioned the validity of the traditionally stated rate. The purpose of this study was to document the results of second-trimester genetic amniocentesis performed at our perinatalogy clinic. Study Design: A retrospective review of all the amnio...

Mid-trimester amniocentesis fetal loss rate.

OBJECTIVE To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. OUTCOME Reduction of benign biopsy rates. BENEFITS To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. SUMMARY STATEMENT The risk of postproc...

Infliximab-associated third nerve palsy.

traoperatively. No attempt was made to drain the subretinal fluid, and no laser photocoagulation was performed. No retinal breaks were identified. The vitreous cavity was filled with 20% sulfur hexafluoride gas and the patient maintained face-down positioning for 1 week. One week postoperatively, the retinal detachment had resolved, and the visual acuity improved to 20/ 200 OD. At the 1 month v...